[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337161-105":59,"doc-detail-337161-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","continuous-prediction-for-tumor-mutation-burden-based-on-transcriptional-data-in-gastrointestinal-cancers","Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers","","Tumor mutation burden (TMB) serves as a biomarker for immune checkpoint inhibitor use, but whole-exome sequencing and gene panel approaches for TMB detection are costly. This study builds a gastrointestinal-tumor TMB prediction model using TCGA transcriptome data. Transcriptome, somatic mutation, and clinical data from esophageal, stomach, colon, and rectal cancers are analyzed with R, including functional enrichment and single-sample GSEA. A deep neural network trained after optimization predicts TMB with strong correlation between predicted and observed values.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/continuous-prediction-for-tumor-mutation-burden-based-on-transcriptional-data-in-gastrointestinal-cancers/337161/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/continuous-prediction-for-tumor-mutation-burden-based-on-transcriptional-data-in-gastrointestinal-cancers/337161.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why predict tumor mutation burden (TMB) instead of measuring it directly?","Question",{"text":112,"@type":113},"TMB is valuable for immune checkpoint inhibitor utilization, but measuring it via whole-exome sequencing or cancer gene panels is costly. This motivates a transcriptome-based prediction approach.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and analyses support the TMB prediction model?",{"text":117,"@type":113},"The model uses transcriptome data, somatic mutation data, and clinical data from four gastrointestinal tumors in TCGA. Analyses include mutation visualization, differential expression, enrichment, GSEA, ssGSEA, and clinic-associated TMB estimation.",{"name":119,"@type":110,"acceptedAnswer":120},"How accurate is the deep neural network (DNN) TMB prediction?",{"text":121,"@type":113},"After model optimization with a genetic algorithm, the Pearson correlation between predicted and actual TMB is reported as 0.98 (training), 0.82 (validation), and 0.92 (testing). The corresponding R2 values are 0.95, 0.82, and 0.7.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337161,1790210577,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Hu et al.  \nBMC Medical Informatics and Decision Making [https://doi.org/10.1186/s12911-024-02794-8](https://doi.org/10.1186/s12911-024-02794-8)  \n(2024) 24:384  \nBMC Medical Informatics and Decision Making  \n RESEARCH Open Access  \nContinuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers  \nBeibei Hu 1, Guohui Yin2, Jialin Zhu1, Yi Bai 1 and Xuren Sun1*  \nAbstract  \nBackground Tumor mutation burden (TMB) has been considered a biomarker for utilization of immune checkpoint inhibitors(ICIs), but whole exome sequencing(WES) and cancer gene panel(CGP) based on next generation sequencing forTMB detection are costly. Here, we use transcriptome data of TCGA to construct a model forTMB prediction in gastrointestinal tumors.  \nMethods Transcriptome data, somatic mutation data and clinical data of four gastrointestinal tumors from TCGA, including esophageal cancer (ESCA), stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) . Using R, we performed visual analysis of somatic mutation data, differentially expressed genes (DEGs) function enrichment analysis, gene set enrichment analysis (GSEA), and estimated TMB value in clinic. Finally, a deep neural network (DNN) model was constructed forTMB prediction.  \nResults Visualization of somatic mutation data summarized the classification of mutation, frequency of each mutation type, and top-mutated genes. GSEA showed the enrichment of CD4+/CD8+ T cells in the high TMB group and the activation of tumor suppressing pathways. Single-sample GSEA (ssGSEA) manifested that the high-TMB group had higher level of multiple immune cells infiltration. In addition, distribution of TMB was related to clinical parameters.  \nLike age, M stage, N stage, AJCC stage, and overall survival(OS) . After model optimization using genetic algorithm, in the training set, validation set, and testing set, the Pearson relevance coefficient r between predicted values and actual values reaches 0 . 98, 0 . 82, and 0. 92, respectively; the coefficient of determination R2 is 0 . 95, 0 . 82, and 0. 7, respectively.  \nConclusion TMB correlates with clinicopathological parameters in gastrointestinal carcinoma, and patients with high TMB have higher levels of immune infiltration. In addition, the DNN model based on 31 genes predicts TMB of gastrointestinal tumors in a high accuracy.  \nKeywords Gastrointestinal cancers, Tumor mutation burden, Deep neural network, Transcriptome, Prediction model  \n*Correspondence: Xuren Sun[sxr679@126.com](sxr679@126.com)  \n1 Department of Gastroenterology, First Affiliated Hospital of China Medical University, Shenyang, China  \n2 Key Laboratory of Traffic Safety On Track (Central South University), Ministry of Education, School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China  \nIntroduction  \nThe latest research shows that in 2020, the number of new cancer patients worldwide reached nearly 20 million, and nearly half of them died. Breast cancer accounted for the first place in all cases, and colorectal cancer and gastric cancer ranked third and fifth of which the deaths ranked second and fourth respectively. It is estimated  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the art","cbCaidpcYUTDnMhw","https://ap.wps.com/l/cbCaidpcYUTDnMhw","pdf",8096141,14,"English","# Abstract\n# Background\n# Methods\n## Data sources and analysis\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"Why predict tumor mutation burden (TMB) instead of measuring it directly?\",\"answer\":\"TMB is valuable for immune checkpoint inhibitor utilization, but measuring it via whole-exome sequencing or cancer gene panels is costly. This motivates a transcriptome-based prediction approach.\"},{\"question\":\"What data and analyses support the TMB prediction model?\",\"answer\":\"The model uses transcriptome data, somatic mutation data, and clinical data from four gastrointestinal tumors in TCGA. Analyses include mutation visualization, differential expression, enrichment, GSEA, ssGSEA, and clinic-associated TMB estimation.\"},{\"question\":\"How accurate is the deep neural network (DNN) TMB prediction?\",\"answer\":\"After model optimization with a genetic algorithm, the Pearson correlation between predicted and actual TMB is reported as 0.98 (training), 0.82 (validation), and 0.92 (testing). The corresponding R2 values are 0.95, 0.82, and 0.7.\"}]","Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers | PDF",1790017945,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/470e5acc0a5f96136be7a32a820b4030.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08b33ddbfa2c49082470c3e90eb22f03.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2f2e7fc69b359da6ce77e479efdc64c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44caecd51dce874444d561ce059de040.webp",980,1301]